Literature DB >> 10532202

Significance of the human immunodeficiency virus infection in patients submitted to cardiac surgery.

R Zeigler, M Sabbaga Amato, T M Varejão Strabelli, L F Aranha Camargo, M Grinberg, A Domingos Jatene.   

Abstract

BACKGROUND: To realize if cardiac surgery could interfere with the evolution of HIV infected patients to the acquired immunodeficiency syndrome (AIDS).
METHODS: The study group consisted of 30 HIV positive patients (0.21%) among 14,785 who underwent cardiac surgery at the Heart Institute of University of Sao Paulo Medical School (Incor-FMUSP) from November 1988 to December 1994. Patients were followed up until they were discharged from hospital and a new contact was kept at the end of the first semester of 1995.
RESULTS: All patients were asymptomatic at the time they were operated. Two patients progressed to death during hospitalization due to non-infectious complications and other three patients could not be traced. After all 25 patients had their progression evaluated. Six patients (24%) died within a period ranging from 1 to 46 months (average=17 months): 2 due to bacterial pneumonia and 04 due to AIDS-related complications. The average follow-up period for the 19 surviving patients was 33.6 months (ranging from 13 to 74 months), and only one of them (5.3%) saw the infection progress to AIDS. In summary, 5/25 (20%) saw HIV infection progress to AIDS within a maximum period of 74 months.
CONCLUSIONS: Data available up to now show no conclusive evidence of acceleration of HIV into AIDS associated with cardiac surgery.

Entities:  

Mesh:

Year:  1999        PMID: 10532202

Source DB:  PubMed          Journal:  J Cardiovasc Surg (Torino)        ISSN: 0021-9509            Impact factor:   1.888


  2 in total

1.  Cardiac surgery in patients infected with human immunodeficiency virus.

Authors:  C Abad; M A Cárdenes; P C Jiménez; M V Armas; P Betancor
Journal:  Tex Heart Inst J       Date:  2000

2.  Successful aortic valve replacement in a patient with AIDS.

Authors:  L Penninga; J R Lahpor; L R van der Wieken
Journal:  Neth Heart J       Date:  2002-06       Impact factor: 2.380

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.